Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ferretti

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
American Journal of Hematology|July 30, 2021
Prognostic impact of somatic mutations on time to first treatment: Results of targeted next-generation sequencing in 211 patients with early stage chronic lymphocytic leukemiaMarzia Varettoni, Ester Orlandi, Silvia Zibellini, et al.
British Journal of Haematology|July 6, 2019
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disordersMarzia Varettoni, Silvia Zibellini, Emanuela Boveri, et al.
Blood|February 21, 2014
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosisElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Leukemia|October 10, 2015
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasmsD Pietra, E Rumi, V V Ferretti, et al.
Molecular Psychiatry|September 8, 2019
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humansG M Leggio, S A Torrisi, R Mastrogiacomo, et al.
Haematologica|November 9, 2014
The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infectionLuca Arcaini, Davide Rossi, Marco Lucioni, et al.
American Journal of Hematology|August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapiesMarzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.
Hipertension Y Riesgo Vascular|July 26, 2025
Statins and preeclampsia: An update from the Working Group on Hypertension in Women, Argentine Society of HypertensionA M Ghelfi, G Miranda, L S Voto, et al.
Leukemia|June 18, 2014
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromesM G Della Porta, E Travaglino, E Boveri, et al.
British Journal of Haematology|July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMOIrit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|July 30, 2021
Prognostic impact of somatic mutations on time to first treatment: Results of targeted next-generation sequencing in 211 patients with early stage chronic lymphocytic leukemiaMarzia Varettoni, Ester Orlandi, Silvia Zibellini, et al.
British Journal of Haematology|July 6, 2019
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disordersMarzia Varettoni, Silvia Zibellini, Emanuela Boveri, et al.
Blood|February 21, 2014
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosisElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Leukemia|October 10, 2015
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasmsD Pietra, E Rumi, V V Ferretti, et al.
Molecular Psychiatry|September 8, 2019
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humansG M Leggio, S A Torrisi, R Mastrogiacomo, et al.
Haematologica|November 9, 2014
The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infectionLuca Arcaini, Davide Rossi, Marco Lucioni, et al.
American Journal of Hematology|August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapiesMarzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.
Hipertension Y Riesgo Vascular|July 26, 2025
Statins and preeclampsia: An update from the Working Group on Hypertension in Women, Argentine Society of HypertensionA M Ghelfi, G Miranda, L S Voto, et al.
Leukemia|June 18, 2014
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromesM G Della Porta, E Travaglino, E Boveri, et al.
British Journal of Haematology|July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMOIrit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Pageof 6